130 related articles for article (PubMed ID: 11029468)
21. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.
Song H; Hanlon N; Brown NR; Noble ME; Johnson LN; Barford D
Mol Cell; 2001 Mar; 7(3):615-26. PubMed ID: 11463386
[TBL] [Abstract][Full Text] [Related]
22. Alternative binding modes of an inhibitor to two different kinases.
De Moliner E; Brown NR; Johnson LN
Eur J Biochem; 2003 Aug; 270(15):3174-81. PubMed ID: 12869192
[TBL] [Abstract][Full Text] [Related]
23. Substrate specificity of CDK2-cyclin A. What is optimal?
Stevenson-Lindert LM; Fowler P; Lew J
J Biol Chem; 2003 Dec; 278(51):50956-60. PubMed ID: 14506259
[TBL] [Abstract][Full Text] [Related]
24. The cell cycle inhibitor p21CIP is phosphorylated by cyclin A-CDK2 complexes.
Jaumot M; Estañol JM; Casanovas O; Graña X; Agell N; Bachs O
Biochem Biophys Res Commun; 1997 Dec; 241(2):434-8. PubMed ID: 9425288
[TBL] [Abstract][Full Text] [Related]
25. The cdk2 binding domain of p27Kip correlates with the inhibition of the kinase activity of cdk2/cyclin complexes.
Kwon TK; Buchholz MA; Nordin AA
Biochem Biophys Res Commun; 1996 Mar; 220(3):703-9. PubMed ID: 8607829
[TBL] [Abstract][Full Text] [Related]
26. Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate.
Davies TG; Tunnah P; Meijer L; Marko D; Eisenbrand G; Endicott JA; Noble ME
Structure; 2001 May; 9(5):389-97. PubMed ID: 11377199
[TBL] [Abstract][Full Text] [Related]
27. Cyclin E-CDK2 is a regulator of p27Kip1.
Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex.
Rogatsky I; Trowbridge JM; Garabedian MJ
J Biol Chem; 1999 Aug; 274(32):22296-302. PubMed ID: 10428798
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
Schulze-Gahmen U; Jung JU; Kim SH
Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
[TBL] [Abstract][Full Text] [Related]
30. Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro.
Higashi H; Suzuki-Takahashi I; Taya Y; Segawa K; Nishimura S; Kitagawa M
Biochem Biophys Res Commun; 1995 Nov; 216(2):520-5. PubMed ID: 7488142
[TBL] [Abstract][Full Text] [Related]
31. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.
Connell-Crowley L; Solomon MJ; Wei N; Harper JW
Mol Biol Cell; 1993 Jan; 4(1):79-92. PubMed ID: 8443411
[TBL] [Abstract][Full Text] [Related]
33. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
Saville MK; Watson RJ
Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
[TBL] [Abstract][Full Text] [Related]
34. Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase.
Chiariello M; Gomez E; Gutkind JS
Biochem J; 2000 Aug; 349 Pt 3(Pt 3):869-76. PubMed ID: 10903150
[TBL] [Abstract][Full Text] [Related]
35. The role of Thr160 phosphorylation of Cdk2 in substrate recognition.
Holmes JK; Solomon MJ
Eur J Biochem; 2001 Sep; 268(17):4647-52. PubMed ID: 11532001
[TBL] [Abstract][Full Text] [Related]
36. A novel member of the cyclin-dependent kinase family in Paramecium tetraurelia.
Zhang H; Berger JD
J Eukaryot Microbiol; 1999; 46(5):482-91. PubMed ID: 10519216
[TBL] [Abstract][Full Text] [Related]
37. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
Lowe ED; Tews I; Cheng KY; Brown NR; Gul S; Noble ME; Gamblin SJ; Johnson LN
Biochemistry; 2002 Dec; 41(52):15625-34. PubMed ID: 12501191
[TBL] [Abstract][Full Text] [Related]
38. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
Luciani MG; Hutchins JR; Zheleva D; Hupp TR
J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
[TBL] [Abstract][Full Text] [Related]
39. Matrix-independent activation of phosphatidylinositol 3-kinase, Stat3, and cyclin A-associated Cdk2 Is essential for anchorage-independent growth of v-Ros-transformed chicken embryo fibroblasts.
Uttamsingh S; Zong CS; Wang LH
J Biol Chem; 2003 May; 278(21):18798-810. PubMed ID: 12646574
[TBL] [Abstract][Full Text] [Related]
40. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
